• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Curr Drug Discov Technol . In Silico Identification of Endemic Plant-Derived Phytocompounds Targeting H5N1 Influenza Proteins via Molecular Docking

tetano

Editor, Senior Moderator
Curr Drug Discov Technol


. 2025 Sep 11.
doi: 10.2174/0115701638391333250812114926. Online ahead of print. In Silico Identification of Endemic Plant-Derived Phytocompounds Targeting H5N1 Influenza Proteins via Molecular Docking and ADME Profiling

Tarik Corbo[SUP] 1 [/SUP], Abdurahim Kalajdzic[SUP] 1 [/SUP], Naris Pojskic[SUP] 1 [/SUP], Kasim Bajrovic[SUP] 1 [/SUP]



Affiliations
Abstract

Introduction: This study investigates the molecular docking of 306 phytochemicals from Iris, Daphne, and Chrysosplenium species against three key proteins of the H5N1 influenza virus: neuraminidase, polymerase, and hemagglutinin. Phytochemicals are recognized for their antiviral potential, but interactions between compounds from these genera and H5N1 proteins remain underexplored. Given the ongoing threat of H5N1, identifying novel inhibitors is essential. The main intent is to evaluate the binding affinities of selected phytochemicals through molecular docking and assess the drug-likeness of top candidates using pharmacokinetic and physicochemical filters.
Methods: Molecular docking was performed for 306 phytochemicals against the three H5N1 proteins. Fourteen promising compounds were further screened for physicochemical properties, compliance with Lipinski's Rule of Five, Veber's Rule, and PAINS alerts.
Results: All compounds exhibited no PAINS alerts, with several conforming to Lipinski's Rule of Five and Veber's Rule. Edgeworoside A emerged as the top-performing compound, showing strong binding affinity across all three targets and favorable interaction profiles. Triumbellin and daphnogi-rin A exhibited significant binding affinity for hemagglutinin and neuraminidase, as well as for polymerase, respectively. Compounds such as 3-isobutenylquercetin, irisoid E, junipegenin A, daphne-toxin, and excoecariatoxin exhibited high binding potential without violating drug-likeness criteria.
Conclusion: Several phytochemicals, particularly edgeworoside A, demonstrate promising multi-target potential against H5N1 influenza proteins. These findings highlight the therapeutic relevance of compounds from underexplored plant genera and support their further development through in vitro, in vivo, and preclinical studies.

Keywords: H5N1.; Phytochemicals; antiviral; drug discovery; in silico; pharmacokinetics.

 
Back
Top Bottom